IL-6 Modulates CD5 Expression in B Cells from Patients with Lupus by Regulating DNA Methylation
Open Access
- 1 May 2009
- journal article
- Published by The American Association of Immunologists
- Vol. 182 (9), 5623-5632
- https://doi.org/10.4049/jimmunol.0802412
Abstract
B lymphocytes from patients with systemic lupus erythematosus (SLE) are characterized by reduced expression levels of membrane CD5. Recent studies from our laboratory have revealed that the level of membrane CD5 is determined by the relative level of two alternative CD5 isoforms; CD5-E1A, which is expressed on the membrane, and CD5-E1B, which is retained in the cytoplasm. Using bisulfite sequencing and methylation-sensitive endonuclease assays we show that the promoter for the alternative CD5-E1B isoform is demethylated in B cells from patients with SLE but not in healthy controls. We go on to show that differential methylation is more pronounced following BCR engagement. As a result of this demethylation, CD5-E1B mRNA is transcribed at the expense of CD5-E1A mRNA transcription. We provide further evidence that production of high IL-6 levels by SLE B cells abrogates the ability of SLE B cells to induce DNA methyl transferase (DNMT1) and then to methylate DNA, an effect that is reversed in the presence of a blocking Ab to the IL-6 receptor. The pattern of demethylation of CpG islands in the CD5-E1B promoter in SLE B cells is similar to those in B cells from healthy controls stimulated in the presence of IL-6, or treated with the methylation inhibitor PD98059. The study reveals that engagement of the BCR with constitutive IL-6 down-regulates the level of membrane CD5, which negatively regulates BCR signaling, in SLE B cells. This altered signaling could, in turn, promote the activation and expansion of autoreactive B cells in SLE patients.Keywords
This publication has 40 references indexed in Scilit:
- Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patientsGenes & Immunity, 2008
- Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+T cells from patients with systemic lupus erythematosusImmunology, 2008
- Hypomethylation of interleukin-4 and -6 promoters in T cells from systemic lupus erythematosus patientsActa Pharmacologica Sinica, 2008
- Epigenetics in inflammatory rheumatic diseasesArthritis & Rheumatism, 2007
- Widely variable endogenous retroviral methylation levels in human placentaNucleic Acids Research, 2007
- Interleukin‐6 is responsible for aberrant B‐cell receptor‐mediated regulation of RAG expression in systemic lupus erythematosusImmunology, 2007
- Characterization of the human CD5 endogenous retrovirus-E in B lymphocytesGenes & Immunity, 2005
- Pharmacologic Inhibition of RAF→MEK→ERK Signaling Elicits Pancreatic Cancer Cell Cycle Arrest Through Induced Expression of p27Kip1Cancer Research, 2005
- Activation of mitogen-activated protein kinase through α5/β1 integrin is required for cell cycle progression of B progenitor cell line, Reh, on human marrow stromal cellsExperimental Hematology, 2000
- Treatment of Murine Lupus with CTLA4IgScience, 1994